Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 20, 2019
Decreased Expression of Long Non-Coding RNA GMDS Divergent Transcript (GMDS-DT) is a Potential Biomarker for Poor Prognosis of Hepatocellular CarcinomaDuo Wang, Xiufang Du, Tao Bai, et al.Bioconjugate Chemistry|September 7, 2017
Selective and Cleavable Extraction of Sialo-glycoproteins by Disulfide-Linked Amino-oxy-Functionalized Fe<sub>3</sub>O<sub>4</sub> Magnetic NanoparticlesXiufang Du, Qingke He, Lixia Zhang, et al.Journal of Infection in Developing Countries|February 19, 2020
Serum levels of soluble CD163 and soluble CD14 following antibiotic therapy of patients with acute brucellosisHuali Sun, Rongmeng Jiang, Bing Han, et al.Imeta|August 13, 2024
Single-cell landscape revealed immune characteristics associated with disease phases in brucellosis patientsYi Wang, Siyuan Yang, Bing Han, et al.Journal of Medical Virology|July 10, 2022
Safety and immunogenicity of COVID-19 vaccination in patients with hepatocellular carcinoma (CHESS-NMCID 2101): A multicenter prospective studyXiaolong Qi, Jitao Wang, Qiran Zhang, et al.The New England Journal of Medicine|September 7, 2017
Tiotropium in Early-Stage Chronic Obstructive Pulmonary DiseaseYumin Zhou, Nan-Shan Zhong, Xiaochen Li, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 23, 2021
Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter StudyJingwen Ai, Jitao Wang, Dengxiang Liu, et al.Hepatology International|April 11, 2022
Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter studyJitao Wang, Qiran Zhang, Jingwen Ai, et al.Pageof 2